Abeta aggregation and possible implications in Alzheimer's disease pathogenesis
about
Germline humanization of a murine Aβ antibody and crystal structure of the humanized recombinant Fab fragmentLiuwei Dihuang (LWDH), a traditional Chinese medicinal formula, protects against β-amyloid toxicity in transgenic Caenorhabditis elegansBeta-barrel models of soluble amyloid beta oligomers and annular protofibrils.A review of β-amyloid neuroimaging in Alzheimer's disease.The concentration of soluble extracellular amyloid-β protein in acute brain slices from CRND8 mice.Inhibition of GSK-3 ameliorates Abeta pathology in an adult-onset Drosophila model of Alzheimer's disease.A peptide that binds specifically to the β-amyloid of Alzheimer's disease: selection and assessment of anti-β-amyloid neurotoxic effects.Mechanisms of small-molecule binding to intrinsically disordered proteins.A differential association of Apolipoprotein E isoforms with the amyloid-β oligomer in solution.Membrane cholesterol modulates {beta}-amyloid-dependent tau cleavage by inducing changes in the membrane content and localization of N-methyl-D-aspartic acid receptorsMutation in E1, the ubiquitin activating enzyme, reduces Drosophila lifespan and results in motor impairment.Detection of amyloid plaques targeted by bifunctional USPIO in Alzheimer's disease transgenic mice using magnetic resonance microimagingImpaired adaptive cellular responses to oxidative stress and the pathogenesis of Alzheimer's diseaseCorrelation of amyloid PET ligand florbetapir F 18 binding with Aβ aggregation and neuritic plaque deposition in postmortem brain tissue.Disordered binding of small molecules to Aβ(12-28).Cilostazol Upregulates Autophagy via SIRT1 Activation: Reducing Amyloid-β Peptide and APP-CTFβ Levels in Neuronal CellsGlobal brain delivery of neprilysin gene by intravascular administration of AAV vector in mice.Pulsed hydrogen-deuterium exchange mass spectrometry probes conformational changes in amyloid beta (Aβ) peptide aggregation.Heterogeneity of microglial activation in the innate immune response in the brain.Misfolded proteins and neurodegeneration: role of non-native cytochrome c in cell death.Stimulation-dependent intraspinal microtubules and synaptic failure in Alzheimer's disease: a review.Latrepirdine: molecular mechanisms underlying potential therapeutic roles in Alzheimer's and other neurodegenerative diseasesCHOLESTEROL AND NEURONAL SUSCEPTIBILITY TO BETA-AMYLOID TOXICITY.PROTECTIVE EFFECT OF IRIS GERMANICA L. IN Β-AMYLOID-INDUCED ANIMAL MODEL OF ALZHEIMER'S DISEASE.A novel antagonistic role of natural compound icariin on neurotoxicity of amyloid β peptide.Modulation of amyloid-β 1-42 structure and toxicity by proline-rich whey peptides.Detection of amyloid plaques targeted by USPIO-Aβ1-42 in Alzheimer's disease transgenic mice using magnetic resonance microimaging.Poly-N-methylated Aβ-Peptide C-Terminal fragments (MEPTIDES) reverse the deleterious effects of amyloid-β in rats.Attenuation of β-Amyloid Toxicity In Vitro and In Vivo by Accelerated Aggregation.Amelioration of amyloid β-induced cognitive deficits by Zataria multiflora Boiss. essential oil in a rat model of Alzheimer's disease.Shengmai Formula Ameliorates Pathological Characteristics in AD C. elegans.
P2860
Q27646600-65C2E254-C154-4CF6-9F26-B3FE6C206994Q28483117-796C325C-4BFF-44B8-86D3-3D3AA005EC2DQ30156038-13E9CA5E-4325-4343-BF80-CAC413230CD0Q30870063-42F917ED-DA94-4CEB-B5C0-B706A5AEA31EQ30994762-BB6112A6-D7B6-4AF2-8AEB-6ED6C26127C0Q33687072-3ED17D70-63F7-4910-BB59-9D15DB691846Q34079353-3011D8A4-6A91-44EF-AEED-AFB49A081FEBQ34417638-3863BC91-BD69-4DA5-97B9-ED78569AAC9EQ34468854-264EAD4E-32AA-49D3-A790-54DA7C0E87C3Q34489199-6C72E4D2-1BE9-40D7-8706-C17AB2003370Q34574992-0A835695-301C-4F43-8A2E-4AA772635302Q34611770-B3923941-8AE5-4E51-A3CE-1780B5E9465BQ34700226-90E0656B-A318-4BC7-82D9-AD3A758FB2EBQ35776066-E0E3626E-98B0-4594-97C4-D5486AB55890Q35842197-FA75FEAA-2F4A-496F-A567-F0E521D7C4C0Q35921338-BFDFE3B0-2EBF-4640-A00E-A7154563843EQ36693341-879590CA-FB2D-44EB-AE26-B1657F0A18F8Q37157432-A19E05D2-5918-4784-8F17-9F53656025E0Q37572598-2A317BA2-18BC-4E22-992D-86D308747FA0Q37775035-3D2F3E01-4088-4B7C-ADD1-B42702EA8361Q38000563-AEB2EBE3-34AE-49F2-A9F5-7B3CA69F6B43Q38168475-E9FD013E-6897-4EB5-9FA8-CD722FA6AAB0Q38262127-55A1F88B-DA7A-48D9-A399-8254AA13442AQ38714669-36D1E460-4EE1-4B46-847B-11E886D88D1DQ38836535-30A2543A-4538-423F-94CD-BE725721B1C8Q39271013-31394D44-E159-4DF7-A384-DE40988CB7FBQ42725476-79FF00C5-6F67-4E3E-9815-828305B953C3Q47673729-F705FA8A-03F8-470B-9DB4-8E3A0FDCF8ABQ48788932-F5D86728-DC65-4ABE-AD82-217307BF15A9Q50780400-E3768397-729D-4F37-BD72-429658B69C65Q53373650-CF1A59ED-0AEA-4D1A-ADCD-2812DC40A5E9
P2860
Abeta aggregation and possible implications in Alzheimer's disease pathogenesis
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Abeta aggregation and possible implications in Alzheimer's disease pathogenesis
@en
Abeta aggregation and possible implications in Alzheimer's disease pathogenesis.
@nl
type
label
Abeta aggregation and possible implications in Alzheimer's disease pathogenesis
@en
Abeta aggregation and possible implications in Alzheimer's disease pathogenesis.
@nl
prefLabel
Abeta aggregation and possible implications in Alzheimer's disease pathogenesis
@en
Abeta aggregation and possible implications in Alzheimer's disease pathogenesis.
@nl
P2093
P2860
P921
P1476
Abeta aggregation and possible implications in Alzheimer's disease pathogenesis
@en
P2093
Ashok K Dubey
Ian G Macreadie
Prashant R Bharadwaj
Ralph N Martins
P2860
P304
P356
10.1111/J.1582-4934.2009.00609.X
P577
2009-03-01T00:00:00Z